03 February 2023
The Minister of Health of the Russian Federation described the current situation with the domestic production of substances for antibiotics as stable. The official also added that 70% of medicines from the vital and essential drugs (VED) list are produced in Russia.
“Due to the fact that during the COVID-19 epidemic the Ministry of Industry and Trade, together with the Ministry of Health, supported the development of the substances production [for antibiotics], we actually have a fairly stable situation today, although we need to make another component for antibiotics of the semi-synthetic group,” he said at an expanded meeting of the Federation Council Committee on Social Politics.
“There are different degrees of localization, and seeing this, the Ministry of Industry and Trade has taken large-scale and significant steps to support the production of substances and components for drugs manufacture,” the minister added.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024